Pulmonx (LUNG) Change in Cash (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Cash data on file, last reported at $1.1 million in Q3 2025.

• Change in Cash for Q3 2025 came in at $1.1 million, up 818.54% year-over-year; the trailing twelve-month figure through Sep 2025 was $13.2 million (up 141.88% YoY), and the FY2024 annual result was -$12.6 million, up 30.58% from the prior year.
• Change in Cash climbed to $1.1 million in Q3 2025 per LUNG's latest filing, from $913000.0 in the prior quarter.
• Over five years, Change in Cash peaked at $8.7 million in Q1 2023 and troughed at -$39.6 million in Q4 2021.
• A 5-year average of -$8.2 million and a median of -$8.6 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2021 and 2025: Change in Cash tumbled 1406.63% in 2021, then jumped 818.54% in 2025.
• A 5-year view of Change in Cash shows it stood at -$39.6 million in 2021, then soared by 73.06% to -$10.7 million in 2022, then declined by 6.85% to -$11.4 million in 2023, then surged by 166.61% to $7.6 million in 2024, then tumbled by 85.71% to $1.1 million in 2025.
• Business Quant data shows LUNG's Change in Cash at $1.1 million in Q3 2025, $913000.0 in Q2 2025, and $3.6 million in Q1 2025.